nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—HRH2—gastric juice—pancreatic cancer	0.219	0.846	CbGeAlD
Tolazoline—HRH2—digestive system—pancreatic cancer	0.0133	0.0516	CbGeAlD
Tolazoline—ADRA2A—islet of Langerhans—pancreatic cancer	0.00829	0.032	CbGeAlD
Tolazoline—ADRA2C—pancreas—pancreatic cancer	0.0073	0.0282	CbGeAlD
Tolazoline—ADRA2A—pancreas—pancreatic cancer	0.00583	0.0225	CbGeAlD
Tolazoline—HRH1—digestive system—pancreatic cancer	0.00507	0.0196	CbGeAlD
Tolazoline—HRH2—GPCR downstream signaling—AKT1—pancreatic cancer	0.000121	0.000164	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—STK11—pancreatic cancer	0.00012	0.000162	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CASP3—pancreatic cancer	0.00012	0.000162	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—HRAS—pancreatic cancer	0.000119	0.000161	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000119	0.000161	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TERT—pancreatic cancer	0.000119	0.00016	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CCND1—pancreatic cancer	0.000117	0.000158	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000117	0.000158	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CXCL8—pancreatic cancer	0.000117	0.000157	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CTNNB1—pancreatic cancer	0.000116	0.000156	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SMAD4—pancreatic cancer	0.000116	0.000156	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000114	0.000154	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—KRAS—pancreatic cancer	0.000114	0.000154	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HIF1A—pancreatic cancer	0.000114	0.000153	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	0.000114	0.000153	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MMP9—pancreatic cancer	0.000114	0.000153	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TSC2—pancreatic cancer	0.000113	0.000153	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000113	0.000153	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HES1—pancreatic cancer	0.000113	0.000152	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PTEN—pancreatic cancer	0.000113	0.000152	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—AKT1—pancreatic cancer	0.000113	0.000152	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000112	0.000152	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CG—pancreatic cancer	0.000112	0.000151	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TERT—pancreatic cancer	0.000111	0.00015	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—APOE—pancreatic cancer	0.000111	0.00015	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	0.000111	0.00015	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—AKT1—pancreatic cancer	0.00011	0.000149	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—KDR—pancreatic cancer	0.000109	0.000147	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000109	0.000147	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000108	0.000146	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PPARG—pancreatic cancer	0.000108	0.000146	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HIF1A—pancreatic cancer	0.000106	0.000143	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000106	0.000143	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TSC2—pancreatic cancer	0.000106	0.000143	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SMAD4—pancreatic cancer	0.000105	0.000142	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—AKT1—pancreatic cancer	0.000105	0.000142	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—PIK3CA—pancreatic cancer	0.000105	0.000141	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—SRC—pancreatic cancer	0.000105	0.000141	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000104	0.000141	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000104	0.00014	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—APOE—pancreatic cancer	0.000104	0.00014	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NFKBIA—pancreatic cancer	0.000103	0.00014	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HES1—pancreatic cancer	0.000103	0.000139	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NOTCH1—pancreatic cancer	0.000102	0.000138	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000102	0.000138	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—VEGFA—pancreatic cancer	0.000102	0.000137	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—KDR—pancreatic cancer	0.000102	0.000137	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—TP53—pancreatic cancer	0.000101	0.000137	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—STAT3—pancreatic cancer	0.000101	0.000136	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—APOE—pancreatic cancer	0.000101	0.000136	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—NRAS—pancreatic cancer	0.000101	0.000136	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CG—pancreatic cancer	0.0001	0.000135	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—NRAS—pancreatic cancer	0.0001	0.000135	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EGF—pancreatic cancer	9.91e-05	0.000134	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TERT—pancreatic cancer	9.9e-05	0.000134	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	9.86e-05	0.000133	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CD—pancreatic cancer	9.84e-05	0.000133	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	9.71e-05	0.000131	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—HRAS—pancreatic cancer	9.69e-05	0.000131	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NFKBIA—pancreatic cancer	9.67e-05	0.00013	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOTCH1—pancreatic cancer	9.57e-05	0.000129	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CXCL8—pancreatic cancer	9.48e-05	0.000128	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	9.47e-05	0.000128	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TSC2—pancreatic cancer	9.44e-05	0.000127	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MYC—pancreatic cancer	9.38e-05	0.000127	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CG—pancreatic cancer	9.36e-05	0.000126	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—NRAS—pancreatic cancer	9.36e-05	0.000126	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TGFB1—pancreatic cancer	9.36e-05	0.000126	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	9.29e-05	0.000125	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	9.27e-05	0.000125	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EGF—pancreatic cancer	9.25e-05	0.000125	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APOE—pancreatic cancer	9.24e-05	0.000125	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—EGFR—pancreatic cancer	9.17e-05	0.000124	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—EGFR—pancreatic cancer	9.13e-05	0.000123	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CG—pancreatic cancer	9.09e-05	0.000123	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	9.07e-05	0.000122	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—KDR—pancreatic cancer	9.05e-05	0.000122	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TERT—pancreatic cancer	9.03e-05	0.000122	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	8.89e-05	0.00012	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CD—pancreatic cancer	8.81e-05	0.000119	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PPARG—pancreatic cancer	8.78e-05	0.000118	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.73e-05	0.000118	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—KRAS—pancreatic cancer	8.67e-05	0.000117	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HIF1A—pancreatic cancer	8.63e-05	0.000116	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—KRAS—pancreatic cancer	8.63e-05	0.000116	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	8.61e-05	0.000116	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	8.61e-05	0.000116	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CB—pancreatic cancer	8.58e-05	0.000116	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—AKT1—pancreatic cancer	8.56e-05	0.000115	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—EGFR—pancreatic cancer	8.53e-05	0.000115	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	8.53e-05	0.000115	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTGS2—pancreatic cancer	8.5e-05	0.000115	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	8.45e-05	0.000114	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	8.43e-05	0.000114	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	8.37e-05	0.000113	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	8.34e-05	0.000113	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	8.34e-05	0.000113	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	8.26e-05	0.000111	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGF—pancreatic cancer	8.24e-05	0.000111	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CD—pancreatic cancer	8.23e-05	0.000111	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	8.18e-05	0.00011	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	8.18e-05	0.00011	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.15e-05	0.00011	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	8.09e-05	0.000109	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—KRAS—pancreatic cancer	8.06e-05	0.000109	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	8e-05	0.000108	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PIK3CA—pancreatic cancer	7.96e-05	0.000107	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	7.93e-05	0.000107	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	7.85e-05	0.000106	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	7.78e-05	0.000105	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TP53—pancreatic cancer	7.7e-05	0.000104	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	7.68e-05	0.000104	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	7.6e-05	0.000103	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	7.6e-05	0.000103	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	7.6e-05	0.000103	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	7.52e-05	0.000101	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	7.46e-05	0.000101	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTEN—pancreatic cancer	7.41e-05	0.0001	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—PIK3CA—pancreatic cancer	7.4e-05	9.99e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	7.38e-05	9.96e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—HRAS—pancreatic cancer	7.37e-05	9.94e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	7.33e-05	9.89e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	7.33e-05	9.89e-05	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.26e-05	9.8e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	7.2e-05	9.71e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	7.18e-05	9.68e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CB—pancreatic cancer	7.17e-05	9.68e-05	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	7.13e-05	9.62e-05	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.13e-05	9.61e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	7.06e-05	9.53e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	7.04e-05	9.5e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	6.97e-05	9.4e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	6.93e-05	9.35e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTGS2—pancreatic cancer	6.91e-05	9.31e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCL8—pancreatic cancer	6.89e-05	9.3e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	6.88e-05	9.28e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—HRAS—pancreatic cancer	6.85e-05	9.24e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	6.81e-05	9.19e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	6.69e-05	9.02e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	6.68e-05	9e-05	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—AKT1—pancreatic cancer	6.66e-05	8.98e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	6.64e-05	8.95e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.62e-05	8.93e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CASP3—pancreatic cancer	6.6e-05	8.9e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	6.6e-05	8.9e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	6.55e-05	8.83e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—AKT1—pancreatic cancer	6.5e-05	8.77e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	6.47e-05	8.73e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	6.47e-05	8.73e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCND1—pancreatic cancer	6.42e-05	8.66e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	6.39e-05	8.62e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	6.36e-05	8.58e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	6.27e-05	8.46e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	6.24e-05	8.41e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	6.2e-05	8.36e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	6.15e-05	8.3e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	6.14e-05	8.28e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	6.1e-05	8.23e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	6.05e-05	8.16e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	6.03e-05	8.13e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTEN—pancreatic cancer	6.02e-05	8.12e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	6.01e-05	8.11e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	5.99e-05	8.09e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	5.99e-05	8.08e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	5.94e-05	8.01e-05	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	5.93e-05	8e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	5.92e-05	7.99e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CASP3—pancreatic cancer	5.88e-05	7.93e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	5.83e-05	7.86e-05	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	5.82e-05	7.85e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	5.77e-05	7.78e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	5.75e-05	7.76e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCND1—pancreatic cancer	5.72e-05	7.72e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	5.67e-05	7.64e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	5.61e-05	7.57e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	5.6e-05	7.55e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	5.6e-05	7.55e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	5.56e-05	7.5e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	5.56e-05	7.5e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MMP9—pancreatic cancer	5.56e-05	7.49e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	5.54e-05	7.48e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	5.53e-05	7.46e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PTEN—pancreatic cancer	5.52e-05	7.45e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	5.52e-05	7.44e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	5.5e-05	7.42e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	5.45e-05	7.35e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	5.42e-05	7.31e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	5.41e-05	7.3e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	5.39e-05	7.28e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	5.39e-05	7.27e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	5.36e-05	7.23e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	5.29e-05	7.13e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	5.23e-05	7.06e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	5.22e-05	7.04e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	5.17e-05	6.97e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	5.15e-05	6.95e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	5.14e-05	6.93e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SRC—pancreatic cancer	5.12e-05	6.91e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	5.1e-05	6.87e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	5.06e-05	6.83e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	5.04e-05	6.8e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	5.04e-05	6.79e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	5.03e-05	6.78e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	4.99e-05	6.73e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—STAT3—pancreatic cancer	4.94e-05	6.66e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NRAS—pancreatic cancer	4.93e-05	6.65e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	4.91e-05	6.63e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	4.9e-05	6.6e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	4.85e-05	6.54e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	4.84e-05	6.52e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	4.76e-05	6.42e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	4.68e-05	6.32e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	4.67e-05	6.3e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MYC—pancreatic cancer	4.59e-05	6.19e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	4.58e-05	6.18e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	4.55e-05	6.14e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	4.53e-05	6.11e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	4.5e-05	6.08e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	4.5e-05	6.07e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	4.49e-05	6.06e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	4.49e-05	6.06e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGFR—pancreatic cancer	4.49e-05	6.06e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	4.41e-05	5.94e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	4.37e-05	5.9e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	4.33e-05	5.84e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AKT1—pancreatic cancer	4.27e-05	5.76e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	4.25e-05	5.73e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—KRAS—pancreatic cancer	4.24e-05	5.72e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	4.23e-05	5.71e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	4.18e-05	5.64e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	4.17e-05	5.63e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	4.16e-05	5.61e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	4.09e-05	5.52e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	4.05e-05	5.46e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	3.9e-05	5.26e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	3.87e-05	5.22e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	3.82e-05	5.16e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	3.82e-05	5.16e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TP53—pancreatic cancer	3.77e-05	5.08e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	3.7e-05	4.99e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HRAS—pancreatic cancer	3.6e-05	4.86e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	3.57e-05	4.82e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	3.55e-05	4.79e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	3.54e-05	4.77e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AKT1—pancreatic cancer	3.47e-05	4.68e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	3.44e-05	4.64e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	3.29e-05	4.43e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT1—pancreatic cancer	3.18e-05	4.29e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	3.12e-05	4.21e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	2.9e-05	3.91e-05	CbGpPWpGaD
